日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment Preferences Among Systemic Therapy-Naïve Patients with Atopic Dermatitis or Psoriasis in Germany: A Multicentre Study

德国未接受过系统性治疗的特应性皮炎或银屑病患者的治疗偏好:一项多中心研究

Royeck, Svenja; Bamidis, Anna Daphne; Weckbecker, Conrad; Hofmann, Silke C; Ständer, Sonja; Novak, Natalija; Balakirski, Galina; Wilsmann-Theis, Dagmar

Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope

对 API m 10 同工型和剪接变体的深入了解:不止一个主要的 IgE 结合表位

Paulus-Tremel, Kathrin Elisabeth; Wolff, Michelle Beatrice; Novak, Natalija; Wagner, Nicola; Landgraf, Alisa; Schülke, Stefan; Holzhauser, Thomas; Mahler, Vera

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

阿尼弗鲁单抗对发炎的角质形成细胞具有直接的免疫调节作用:对治疗红斑狼疮皮肤病变的意义。

Kalyniuk Ksenia, Fetter Tanja, Grützbach Marie, Guel Tugce, Novak Natalija, Wenzel Joerg

The respiratory allergy patient's healthcare journey: An international qualitative survey employing an ethnographic approach

呼吸道过敏患者的医疗保健历程:一项采用民族志方法的国际定性调查

Cottet, Julien; Court-Devilliers, Sarah; Caruso, Cristiano; Ahmed, Léa; Delfino Spiga, Arianna; Fabbroni, Ludovica; Tuca Radu, Oana; Scurati, Silvia; Novak, Natalija

Differences in allergen-specific basophil activation and T cell proliferation in atopic dermatitis patients with comorbid allergic rhinoconjunctivitis treated with a monoclonal anti-IL-4Rα antibody or allergen-specific immunotherapy

接受单克隆抗IL-4Rα抗体或过敏原特异性免疫疗法治疗的合并过敏性鼻结膜炎的特应性皮炎患者,其过敏原特异性嗜碱性粒细胞活化和T细胞增殖存在差异

Layritz, Anne-Sophie; Galicia-Carreón, Jorge; Benfadal, Said; Novak, Natalija

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long-term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis

采用脱色聚合提取物进行皮下注射的桦树花粉过敏原免疫疗法,仅在部分对单一过敏原敏感的成人和青少年过敏性鼻炎患者中显示出持续和长期的疗效。

Novak, Natalija; Worm, Margitta; Staubach, Petra; Jutel, Marek; Sager, Angelika; Pfaar, Oliver

Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia

新冠疫苗的罕见不良反应:从超敏反应到血栓形成和血小板减少症

Novak, Natalija; Tordesillas, Leticia; Cabanillas, Beatriz

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"

新冠疫苗过敏反应:IgE、补体还是其他因素?回复:“新冠疫苗过敏反应:是否需要聚乙二醇(PEG)?”

Cabanillas, Beatriz; Akdis, Cezmi A; Novak, Natalija

COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines"

新冠疫苗中除聚乙二醇(PEG)以外的其他潜在致敏成分的作用。回复:“除聚乙二醇以外的其他赋形剂可能导致新冠疫苗中出现严重的超敏反应”

Cabanillas, Beatriz; Akdis, Cezmi A; Novak, Natalija

Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation

新冠病毒mRNA疫苗1273的致敏成分:聚乙二醇和IgG介导的补体激活可能参与其中

Klimek, Ludger; Novak, Natalija; Cabanillas, Beatriz; Jutel, Marek; Bousquet, Jean; Akdis, Cezmi A